Skip to content
HowShorted

Novavax, Inc. short interest in 2018

In 2018, Novavax, Inc.'s disclosed short interest ran from 14.25% of shares outstanding on 12 Jan 2018 to 15.22% on 31 Dec 2018, a change of +0.97 percentage points. The year's high was 16.46% on 31 Jul 2018 and its low 13.97% on 14 Dec 2018, averaging 15.06% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.69 days on 13 Jul 2018. Full history: Novavax, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Novavax, Inc. in 2018

2018 in figures

Start of year
14.25% (12 Jan 2018)
End of year
15.22% (31 Dec 2018)
Change
+0.97 pp
High
16.46% (31 Jul 2018)
Low
13.97% (14 Dec 2018)
Average
15.06%
Highest days to cover
18.69 (13 Jul 2018)
SEC filings marked
8

Every report in 2018

Novavax, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201814.25%2.15
31 Jan 201814.13%3.62
15 Feb 201814.69%5.97
28 Feb 201815.50%3.69
15 Mar 201814.81%5.0110-K filed, results (8-K)
29 Mar 201816.31%6.88
13 Apr 201815.90%5.85
30 Apr 201815.30%10.17
15 May 201814.78%11.2610-Q filed, results (8-K)
31 May 201814.49%12.80
15 Jun 201814.59%9.98
29 Jun 201815.27%9.20
13 Jul 201816.07%18.69
31 Jul 201816.46%15.97
15 Aug 201814.12%12.7710-Q filed, results (8-K)
31 Aug 201814.48%15.58
14 Sep 201814.46%17.82
28 Sep 201815.58%5.14
15 Oct 201816.34%8.21
31 Oct 201815.45%11.31
15 Nov 201814.35%10.4410-Q filed, results (8-K)
30 Nov 201814.94%10.68
14 Dec 201813.97%4.80
31 Dec 201815.22%5.36

See also: Novavax, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.